Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.73)
# 763
Out of 5,124 analysts
86
Total ratings
42.86%
Success rate
11.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PALI Palisade Bio | Initiates: Overweight | $25 | $2.35 | +963.83% | 1 | Dec 29, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Overweight | $540 → $900 | $582.34 | +54.55% | 5 | Dec 19, 2025 | |
| ORKA Oruka Therapeutics | Initiates: Overweight | $75 | $30.31 | +147.44% | 1 | Dec 18, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Maintains: Overweight | $140 → $72 | $6.13 | +1,074.55% | 2 | Nov 11, 2025 | |
| PRTA Prothena Corporation | Maintains: Overweight | $15 → $36 | $9.55 | +276.96% | 5 | Oct 28, 2025 | |
| LBRX LB Pharmaceuticals | Initiates: Overweight | $78 | $22.26 | +250.40% | 1 | Oct 6, 2025 | |
| TENX Tenax Therapeutics | Initiates: Overweight | $20 | $12.20 | +64.00% | 1 | Sep 8, 2025 | |
| IVA Inventiva | Initiates: Overweight | $26 | $4.65 | +459.14% | 1 | Aug 27, 2025 | |
| PLRX Pliant Therapeutics | Maintains: Overweight | $17 → $4 | $1.22 | +227.87% | 2 | Aug 8, 2025 | |
| TVRD Tvardi Therapeutics | Initiates: Overweight | $78 | $4.30 | +1,713.95% | 1 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $93 → $145 | $46.30 | +213.17% | 2 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 | $24.82 | +105.52% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $6 | $1.15 | +421.74% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $48 | $18.16 | +164.32% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $78.41 | +18.61% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $75 | $27.15 | +176.24% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $105 | $42.28 | +148.34% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $37 | $35.08 | +5.47% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $5.24 | +396.18% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $0.53 | +5,146.39% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $46.55 | +108.38% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $270 | $294.74 | -8.39% | 3 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $20.86 | +264.33% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $3.61 | +592.52% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $13.47 | +122.72% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $9.36 | +28.21% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $5.77 | +1,459.79% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 | $8.01 | +2,147.19% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $3.10 | +383.87% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $6.03 | +165.34% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $48.48 | +65.02% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $69.55 | +33.72% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $25.42 | +124.23% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $5.92 | +1,031.76% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $87.34 | -59.93% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $15.77 | +451.68% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $9.32 | +1,777.68% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $63.54 | +13.31% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $9.03 | +453.71% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $0.71 | +5,521.93% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.35 | +5,115.88% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $13.96 | +2,909.67% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $78.99 | -2.52% | 1 | Jul 31, 2020 |
Palisade Bio
Dec 29, 2025
Initiates: Overweight
Price Target: $25
Current: $2.35
Upside: +963.83%
Madrigal Pharmaceuticals
Dec 19, 2025
Maintains: Overweight
Price Target: $540 → $900
Current: $582.34
Upside: +54.55%
Oruka Therapeutics
Dec 18, 2025
Initiates: Overweight
Price Target: $75
Current: $30.31
Upside: +147.44%
Arcturus Therapeutics Holdings
Nov 11, 2025
Maintains: Overweight
Price Target: $140 → $72
Current: $6.13
Upside: +1,074.55%
Prothena Corporation
Oct 28, 2025
Maintains: Overweight
Price Target: $15 → $36
Current: $9.55
Upside: +276.96%
LB Pharmaceuticals
Oct 6, 2025
Initiates: Overweight
Price Target: $78
Current: $22.26
Upside: +250.40%
Tenax Therapeutics
Sep 8, 2025
Initiates: Overweight
Price Target: $20
Current: $12.20
Upside: +64.00%
Inventiva
Aug 27, 2025
Initiates: Overweight
Price Target: $26
Current: $4.65
Upside: +459.14%
Pliant Therapeutics
Aug 8, 2025
Maintains: Overweight
Price Target: $17 → $4
Current: $1.22
Upside: +227.87%
Tvardi Therapeutics
Jun 12, 2025
Initiates: Overweight
Price Target: $78
Current: $4.30
Upside: +1,713.95%
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $46.30
Upside: +213.17%
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $24.82
Upside: +105.52%
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $1.15
Upside: +421.74%
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $18.16
Upside: +164.32%
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $78.41
Upside: +18.61%
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $27.15
Upside: +176.24%
Nov 4, 2024
Initiates: Overweight
Price Target: $105
Current: $42.28
Upside: +148.34%
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $35.08
Upside: +5.47%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $5.24
Upside: +396.18%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $0.53
Upside: +5,146.39%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $46.55
Upside: +108.38%
Jul 1, 2024
Maintains: Overweight
Price Target: $270
Current: $294.74
Upside: -8.39%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $20.86
Upside: +264.33%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $3.61
Upside: +592.52%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $13.47
Upside: +122.72%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $9.36
Upside: +28.21%
Apr 4, 2024
Initiates: Overweight
Price Target: $90
Current: $5.77
Upside: +1,459.79%
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $8.01
Upside: +2,147.19%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $3.10
Upside: +383.87%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $6.03
Upside: +165.34%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $48.48
Upside: +65.02%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $69.55
Upside: +33.72%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $25.42
Upside: +124.23%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $5.92
Upside: +1,031.76%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $87.34
Upside: -59.93%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $15.77
Upside: +451.68%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $9.32
Upside: +1,777.68%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $63.54
Upside: +13.31%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $9.03
Upside: +453.71%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $0.71
Upside: +5,521.93%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.35
Upside: +5,115.88%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $13.96
Upside: +2,909.67%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $78.99
Upside: -2.52%